Invenio Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,110
Closed -$289K 93
2024
Q4
$289K Buy
1,110
+1
+0.1% +$297 0.12% 77
2024
Q3
$357K Buy
1,109
+39
+4% +$12.8K 0.15% 64
2024
Q2
$334K Sell
1,070
-2
-0.2% -$588 0.17% 62
2024
Q1
$305K Buy
1,072
+108
+11% +$31.6K 0.16% 67
2023
Q4
$278K Buy
964
+135
+16% +$36.8K 0.2% 73
2023
Q3
$223K Buy
+829
New +$207K 0.2% 76

Other funds holding AMGN

Invenio Wealth Partners's AMGN Position: Q1 2025 in Review

Invenio Wealth Partners sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,110 shares — an estimated $289K sold.

Invenio Wealth Partners first reported a position in AMGN in Q3 2023 and held it in 6 quarters. The position peaked at $357K in Q3 2024. 2,933 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Invenio Wealth Partners reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Invenio Wealth Partners sold 1,110 Amgen shares in Q1 2025, an estimated $289K.
  • Invenio Wealth Partners first reported a position in Amgen in Q3 2023 and held it in 6 quarters.
  • Invenio Wealth Partners's Amgen position peaked at $357K in Q3 2024.
  • 2,933 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Invenio Wealth Partners's 13F filing for Q1 2025, filed 13 May 2025.